Investor

Remeditex

Last cheque observed Sep 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series C

Cheques on record
0%of best year0cheques in 12 months, 2 on record
Since the last cheque3325days00hrs00min00sec
Median round$39MRounds led0 of 2
Pitch Remeditex

Remeditex highlights

  1. 01

    2 rounds on record

  2. 02

    Mostly Series C: 100% of its rounds

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first2 appearances

  1. 2017

    2 rounds

  2. Sept
    Rodin TherapeuticsSeries C · US · FinSMEs$27MWith 5 others
  3. Jul
    Menlo TherapeuticsSeries C · US · FinSMEs$50MWith 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Quick answers about Remeditex

What does Remeditex invest in?

Remeditex invests most often at Series C (100% of the rounds on record).

How active is Remeditex?

2 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2017.

What has Remeditex invested in recently?

Its most recent investments on record: Rodin Therapeutics (Series C, Sept 2017) and Menlo Therapeutics (Series C, Jul 2017).

How big are Remeditex's cheques?

The median round it joins is $39M.

Is Remeditex investing now?

No investments in the last 12 months; the latest was in Sept 2017.

What kind of investor is Remeditex?

Remeditex is a growth equity firm.

Where does this information on Remeditex come from?

From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it